Clinical utility of the pan-immune-inflammation value in breast cancer patients

BACKGROUND: The newly discovered pan-immune-inflammation value (PIV) has been illustrated to have good prognostic value for cancer patient prognosis. However, the prognostic usefulness of PIV in breast cancer patients is unknown. As a result, to aid the clinic in providing a distinctive and trustwor...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Xiaoyan, Qiao, Boyang, Song, Tingting, Huang, Dan, Zhang, Hui, Liu, Yang, Jin, Qi, Yang, Ming, Liu, Delong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499041/
https://www.ncbi.nlm.nih.gov/pubmed/37711203
http://dx.doi.org/10.3389/fonc.2023.1223786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499041/
https://www.ncbi.nlm.nih.gov/pubmed/37711203
http://dx.doi.org/10.3389/fonc.2023.1223786

Ejemplares similares